10/07/2026
This Thursday, we're going live. 🧬
Our Founder & CEO Yael Weiss sits down with Mahzi investor Vimal Srivastava, who backed us in our private round before the FDA granted MZ-1866 Rare Pediatric Disease Designation. He'll share why he invested early. Yael will share the latest from the first-ever gene therapy trial for Pitt Hopkins syndrome.
Stick around for a live Q&A after the main session.
📅 Thursday, October 8, 10am PT / 1pm ET 📍 Zoom
👇 Save your seat with the link in the comments. Can't make it? Register and we'll send you the replay.